Background-Mineralocorticoid receptor (MR) blockade improves morbidity and mortality among patients with heart failure; however, the underlying mechanisms are still under investigation. We studied left ventricular remodeling after myocardial infarction in mice with cardiomyocyte-specific inactivation of the MR gene (MR MLCCre ) that were generated with a conditional MR allele (MR flox ) in combination with a transgene expressing Cre recombinase under control of the myosin light-chain (MLC2a) gene promoter. Methods and Results-Control (MR flox/flox , MR flox/wt ) and MR MLCCre mice underwent coronary artery ligation. MR ablation had no detectable baseline effect on cardiac morphology and function. The progressive left ventricular chamber enlargement and functional deterioration in infarcted control mice, detected by echocardiography and conductance catheter analysis during the 8-week observation period, were substantially attenuated in MR MLCCre mice. Chronically infarcted MR MLCCre mice displayed attenuated pulmonary edema, reduced cardiac hypertrophy, increased capillary density, and reduced accumulation of extracellular matrix proteins in the surviving left ventricular myocardium. Moreover, cardiomyocyte-specific MR ablation prevented the increases in myocardial and mitochondrial O 2 ⅐Ϫ production and upregulation of the NADPH oxidase subunits Nox2 and Nox4. At 7 days, MR MLCCre mice exhibited enhanced infarct neovessel formation and collagen structural organization associated with reduced infarct expansion. Mechanistically, cardiomyocytes lacking MR displayed accelerated stress-induced activation and subsequent suppression of nuclear factor-B and reduced apoptosis early after myocardial infarction. Conclusion-Cardiomyocyte-specific MR deficiency improved infarct healing and prevented progressive adverse cardiac remodeling, contractile dysfunction, and molecular alterations in ischemic heart failure, highlighting the importance of cardiomyocyte MR for heart failure development and progression. (Circulation. 2011;123:400-408.) The online-only Data Supplement is available with this article at http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.110.983023/DC1.
M ineralocorticoid receptor (MR) blockade reduces morbidity and mortality in patients with heart failure. [1] [2] [3] [4] However, it remains unclear whether the cardioprotective effects of MR antagonists can be attributed to inhibition of the cardiomyocyte MR. While attenuation of left ventricular (LV) dilation and excessive extracellular matrix turnover [5] [6] [7] [8] [9] and prevention of electric remodeling appear to be essential mechanisms of MR antagonism, 10, 11 extracardiac effects such as renal sodium excretion and potassium sparing, restoration of autonomic balance, and improvement in vascular endothelial dysfunction may be of particular importance. 9, [12] [13] [14] 
Clinical Perspective on p 408
To investigate the pathophysiological role of the cardiomyocyte MR in ischemic heart failure, we investigated cardiac remodeling after myocardial infarction (MI) in mice with cardiac myocyte-specific inactivation of the MR gene. LV remodeling after MI is a dynamic time-dependent process involving the infarcted region and the residual viable myocardium. 15 Thinning and dilatation of the infarcted region (infarct expansion) are events in the early phase of healing, followed by progressive cardiomyocyte hypertrophy and extracellular matrix remodeling remote from the infarct site. 15 Accordingly, we studied cellular and molecular alterations in the surviving LV myocardium in the late post-MI phase (8 weeks) and infarct wound healing, expansion, and neovascularization during the early MI phase (1 to 7 days).
Methods
All procedures were approved by the institutional animal research committee.
Generation of MR Mutant Mice and MI
A murine model of MR ablation in cardiomyocytes was generated with a conditional MR allele (MR flox ) 16 and a mouse line expressing Cre recombinase under control of the atrial myosin light chain gene promoter (C57Bl6-Tg-MLC-Creϩ/0; Figure IA in the online-only Data Supplement). 17 MR flox allele and Cre transgene were backcrossed 8 times in C57Bl6; then, MR flox/wt and MR flox/wt mice, as well as MR flox/wt and MR wt/wt MLCCre mice, were crossed to generate breeding pairs; MR flox/flox and MR flox/wt MLCCre were crossed to generate mutant mice (MR flox/flox MLCCreϭMR MLCCre ) and littermate controls (MR flox/flox and MR flox/wt mice).
MI was induced by permanent left coronary artery ligations in male and female mice that were 8 to 12 weeks of age. 18 A total of 207 mice (control, nϭ103; MR MLCCre , nϭ104) were subjected to MI ( Figure II in the online-only Data Supplement). Twenty-four hours after surgery, surviving mice were randomly selected for the early MI phase (1 to 7 days) or the late post-MI phase (56 days). Mice with MI Ͻ40% were excluded from the analyses. The 56-day survival was significantly higher in infarcted MR MLCCre mice (88%) compared with control mice (61%; PϽ0.05). All mice (control, nϭ12; MR MLCCre , nϭ12) that had undergone sham operation (the suture around the coronary artery was not tied) survived.
Isolation of Cardiomyocytes
Isolation of cardiomyocytes from hearts of control and MR MLCCre mice was performed exactly according to AfCS Procedure Protocol PP00000125 (http://www.signaling-gateway.org/reports/v1/CM0005/ CM0005.htm).
An expanded Methods section is available in the online-only Data Supplement.
Statistical Analysis
The results are reported as meanϮSEM or percentile. The Shapiro-Wilk and Levene tests were used to analyze normality and variance homogeneity of residuals, respectively. Statistical analysis was performed by 1-way ANOVA, 2-way ANOVA, or the Kruskal-Wallis test for comparisons among Ն3 groups or unpaired the t test and Mann-Whitney U test for comparisons between 2 groups as appropriate. The Holm posthoc test was used to adjust for multiple comparisons except as otherwise indicated. Linear (Pearson) correlations were estimated. Statistical analysis was performed with StatView 5.0.1 and R, Software Environment for Statistical Computing, Version 2.10.1 (SAS Institute Inc., Cary, NC). Linear mixed-effects models (MIXED) procedure was performed with the SPSS 16.0 statistical software package (SPSS Inc., Chicago, IL). Two-sided P values were used. Values of PϽ0.05 were considered statistically significant.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Cardiac Morphology, Function, and Gene Expression in MR MLCCre Mice
As expected, in isolated cardiomyocytes from MR MLCCre mice, MR protein expression was barely detectable ( Figure  IB in the online-only Data Supplement). We did not detect differences between control and MR-deficient mice regarding hemodynamics, LV structure, and LV function (Figure IC  through IE and Table in the online-only Data Supplement). Microarray analysis revealed that myocardial gene expression of the MR target gene serum/glucocorticoid regulated kinase 1 (SGK1) was downregulated in MR MLCCre mice (2.1-fold versus control; PϽ0.001).
Infarct Size
We used the model of left coronary artery ligation to assess the effect of MR ablation on LV healing and remodeling. Mean infarct sizes were similar among the experimental groups (1 day: control, 51Ϯ3%, nϭ8; MR MLCCre , 50Ϯ2%, nϭ7; 3 days: control, 46Ϯ2%, nϭ7; MR MLCCre , 46Ϯ1%, nϭ6; 7 days: control, 52Ϯ2%, nϭ12; MR MLCCre , 50Ϯ2%, nϭ12), see also the Table.
Aldosterone and Corticosterone Plasma Levels After Infarction
Plasma aldosterone and corticosterone levels were markedly increased after MI ( Figure III in the online-only Data Supplement). A significant positive correlation was observed between aldosterone and corticosterone plasma levels (rϭ0.84, PϽ0.0001). In MR MLCCre mice, corticosterone levels tended to be lower 8 weeks after infarction compared with control mice ( Figure III in the online-only Data Supplement).
Myocardial gene expression and protein expression of the glucocorticoid receptor and 11-␤hydroxysteroid dehydrogenase type 2 (11beta-HSD2) were similar among the experimental groups ( Figure 
Cardiomyocyte-Specific MR Ablation Attenuates Progressive Ventricular Dilation and Improves Cardiac Function After MI
The rightward shift of the pressure-volume curve was prevented in the MR MLCCre mice 8 weeks after MI ( Figure 1A ). LV filling pressure, end-diastolic volume, and end-systolic volume were significantly decreased compared with control mice. Amelioration of LV dilation in MR MLCCre mice was associated with significantly improved LV ejection fraction ( Figure 1A ). The progressive increase in LV end-systolic and end-diastolic areas and diameters observed by serial echocardiography during the 8-week observation period in control mice was attenuated in MR MLCCre mice ( Figure VA to reduced pressure load on the right ventricle and accumulation of pulmonary fluid. These results show that cardiomyocyte-specific MR ablation prevents the progression of postinfarction cardiac dilation, functional deterioration, and failure.
Cardiomyocyte-Specific MR Ablation Prevents Cardiac Hypertrophy and Extracellular Matrix Accumulation After Infarction
Attenuation of LV dilation and failure in chronically infarcted MR MLCCre mice was associated with reduced hypertrophy (LV weight and cardiomyocyte size), increased capillary density ( 
Cardiomyocyte-Specific MR Ablation Prevents Myocardial and Mitochondrial O 2 ⅐؊ Production After Infarction
Oxidant stress plays a key role in the development of adverse cardiac remodeling and contractile dysfunction after MI. 19, 20 Myocardial O 2 ⅐Ϫ production was increased substantially in control mice 8 weeks after infarction and nearly normalized in chronically infarcted MR MLCCre mice ( Figure 3A ). Protein expression of the NADPH oxidase subunits Nox2 and Nox4 was significantly lower in the surviving LV myocardium of MR MLCCre -MI mice ( Figure 3C ). We additionally measured O 2 ⅐Ϫ production in mitochondria isolated from the surviving LV myocardium ( Figure 3B ). Chronic MI led to a significant increase in O 2 ⅐Ϫ production in mitochondria in control mice, which was suppressed in MR MLCCre mice. Furthermore, the role of MR in aldosterone-induced mitochondrial oxidative stress was assessed in isolated adult cardiomyocytes. Aldosterone stimulation significantly increased mitochondrial O 2 ⅐Ϫ production and Nox4 upregulation in cardiomyocytes from control but not MR MLCCre mice ( Figure VII 
Enhanced Infarct Collagen Structural Organization and Reduced Infarct Expansion in MR MLCCre Mice 7 Days After MI
Cardiomyocyte-specific MR ablation also prevented the rightward shift of the pressure-volume curve in the early MI phase ( Figure 4A ). LV filling pressure, LV end-diastolic vol-ume, LV end-systolic volume, and LV ejection fraction were significantly improved 7 days after infarction. MR MLCCre mice exhibited significantly increased scar thickness and reduced infarct expansion index at 7 days ( Figure 4B ). It is noteworthy that, although total scar collagen was unchanged, collagen organization was improved. Sirius Red polarization microscopy revealed mainly a well-organized collagen matrix with uniform, sharply delineated, well-aligned collagen fibers in MR MLCCre -MI mice, in contrast to a disorganized matrix with a predominance of smaller and fragmented collagen fibers in control MI mice ( Figure 4B ). Plasma levels of type I collagen C-terminal telopeptide were significantly lower in MR MLCCre (5.22Ϯ0.7 ng/mL; nϭ7) compared with control mice (8.04Ϯ0.6 ng/mL; nϭ7; PϽ0.05), suggesting less collagen breakdown in MR MLCCre mice 7 days after MI. Collagen fibers are degraded by matrix metalloproteinases (MMPs), leading to thinning and dilatation of the infarcted wall. 21, 22 At 7 days, MMP-9 and MMP-2 activity was more intense in the infarcted wall of control mice compared with MR MLCCre mice ( Figure 4B ).
Enhanced Neovascularization in the Healing Myocardium of MR MLCCre Mice
We observed increased neovascularization in the healing myocardium of MR MLCCre mice 7 days after MI. Immunohistochemical studies revealed increased capillaries and small-lumen vessels in the infarct scar and infarct borders ( Figure 5A ). Vascular endothelial growth factor (VEGF) protein was substantially higher in the infarct area from MR MLCCre compared with control mice 3 days after infarction ( Figure 5B and 5C ). Immunohistochemical staining showed 
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more VEGF-positive endothelial cells in the infarcted myocardium in MR MLCCre mice ( Figure 5B ), suggesting that endothelial cells may represent the source of VEGF. Importantly, more CD31 ϩ cells were found in the healing myocardium of MR MLCCre mice 3 days after infarction ( Figure 5D ).
Targeted Ablation of the MR Allows Cardiomyocytes to Respond Rapidly to Ischemia Through Nuclear Factor-B Activation
To identify a cardiomyocyte-specific mechanism underlying improved healing response to ischemia in infarcted MR MLCCre mice, we focused on nuclear factor-B (NF-B), a key signaling component for early inflammatory activation and healing after MI. 23 Recent data showed that aldosterone via the MR abrogates IB␣ degradation and NF-B activation. 24 In isolated cardiomyocytes from MR MLCCre mice 90 minutes after coronary artery ligation, we found substantially increased NF-B DNA binding activity and lower protein levels of the inhibitory protein IB␣ compared with control ( Figure 6A) .
To test the hypothesis that the cardiomyocyte MR interferes with NF-B activation, we examined regulation of NF-B on tumor necrosis factor-␣ stimulation in cardiomyocytes isolated from adult control and MR MLCCre mice. We observed accelerated activation of NF-B followed by faster suppression in MR knockout cardiomyocytes, accompanied by inverse effects on IB␣ protein ( Figure VIII in the online-only Data Supplement). In cardiomyocytes from control mice, stimulation with tumor necrosis factor-␣ at 30 minutes induced IB␣ protein degradation and maximal induction of NF-B DNA binding activity, which was sustained for up to 60 minutes. In contrast, in MR knockout cardiomyocytes, tumor necrosis factor-␣ induced a decrease in IB␣ protein level and maximal NF-B activation already after 15 minutes, which returned to normal after 60 minutes. These findings indicate that MR ablation accelerates stressinduced NF-B activation and subsequent suppression in cardiomyocytes.
Targeted Ablation of the MR Protects Cardiomyocytes Against Apoptosis
NF-B protects cardiomyocyte from ischemia-induced apoptosis during the first hours after permanent coronary artery ligation, 25 whereas MR activation induces cardiomyocyte apoptosis. 26, 27 Accordingly, we studied whether MR ablation protects ischemic cardiomyocytes from apoptosis. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) analyses were performed 24 hours after MI. The rate of apoptosis in the peri-infarct region was decreased in MR MLCCre mice compared with control ( Figure 6B ). These results reveal protection against apoptosis by cardiomyocytespecific MR ablation early after MI.
Accelerated Recruitment of Inflammatory Cells in the Healing Myocardium of MR MLCCre Mice
NF-B plays a critical role in the induction of RANTES, 28 a potent chemoattractant for monocytes 29 and neutrophils. 30 Of note, at 1 day after MI, we found significantly higher RANTES protein expression in the injured myocardium of MR MLCCre mice (158Ϯ12 pg/mg protein) compared with control mice (86Ϯ7 pg/mg protein; PϽ0.05), associated with more infiltrating neutrophils and monocytes ( Figure 6C ). 
Discussion
MR antagonism beneficially modulates heart failure progression and survival, but the contribution of renal, vascular, or cardiac MR blockade remained obscure. By cell-specific ablation, the present study proves a pathogenetic role of the cardiomyocyte MR for ventricular remodeling after MI. Selective cardiomyocyte MR ablation in vivo improved infarct healing and protected against progressive adverse cardiac remodeling and molecular alterations in ischemic heart failure, thus highlighting the importance of the cardiomyocyte MR for heart failure development and progression after MI.
Chronic ventricular remodeling after MI involves cardiac hypertrophy and extracellular matrix accumulation remote from the infarct site, leading to chamber dilation, contractile dysfunction, and heart failure. 15 Targeted overexpression of the human MR in the heart resulted in dilated cardiomyopathy, emphasizing a role for MR in mediating pathological hypertrophy. 31 On the other hand, MR antagonism reduced cardiac hypertrophy and maladaptive remodeling after MI, 7 but this may be mediated by extracardial effects. In the present study, cardiomyocyte MR deficiency prevented cardiac hypertrophy, as evidenced by the reduction in heart weight, myocyte cross-sectional area, and expression of fetal genes such as ␤-myosin heavy chain in chronically infarcted MR MLCCre mice, thus proving the involvement of cardiomyocyte MR-dependent pathways in the hypertrophic response after MI. In addition to biomechanical stress such as chronic volume and pressure overload, several neurohumoral factors regulate cardiomyocyte hypertrophy. Cardiomyocyte MR ablation prevented ACE upregulation, which may explain not only the reduced cardiomyocyte hypertrophy and fibrosis but also the attenuation of oxidative stress in the surviving LV myocardium of chronically infarcted MR MLCCre mice. Aldosterone, via MR activation, upregulates ACE expression in 
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cardiomyocytes, suggesting the existence of a positive feedback pathway from MR to ACE within the cardiomyocyte renin-angiotensin-aldosterone system. [32] [33] [34] Using mice with conditional cardiomyocyte-restricted human MR overexpression, Di Zhang et al 33 demonstrated interaction of angiotensin II with cardiomyocyte MR to induce cardiac fibrosis and remodeling through generation of reactive oxygen species. Angiotensin II-induced myocardial hypertrophy critically involves mitochondrial reactive oxygen species production, 35 which was also diminished in MR MLCCre mice after MI. Mitochondrial oxidative stress is sufficient to promote cardiac remodeling and failure postinfarction. 20 Aldosterone has been shown to stimulate myocardial and vascular reactive oxygen species generation. 14, 26, 36 Our study provides evidence that cardiomyocyte MR ablation prevents myocardial oxidative stress in vivo and attenuates superoxide anion production in mitochondria, likely secondary to diminished upregulation of the NADPH oxidase subunits Nox2 and Nox4. 37 Moreover, our studies performed on cardiomyocytes isolated from adult control and MR MLCCre mice are the first directly linking aldosterone action in cardiomyocytes to induction of mitochondrial oxidative stress and Nox4 expression via the MR.
In the context of MI and oxidative stress, 27, 38 glucocorticoids may activate cardiomyocyte MR and mimic the pathophysiological effects of aldosterone. The highly significant positive correlation between aldosterone and corticosterone plasma levels suggests a mechanistic interdependence. Supporting this notion, cortisol levels, as useful predictors of cardiac events in patients with CHF, correlated with plasma aldosterone levels. 39 Nevertheless, higher serum levels of both cortisol and aldosterone are independent, complementary, and incremental predictors of all-cause mortality risk in patients with chronic heart failure. 40 Conceivably, improved remodeling in MR MLCCre mice may also be related to the absence of cardiomyocyte MR activation by glucocorticoids.
The direct MR target gene SGK1 was identified as downregulated in the heart of MR MLCCre mice through the use of microarray analysis. SGK1 is dynamically regulated in cardiomyocytes and enhances the cardiomyocyte hypertrophic response. 41 SGK1 deficiency abrogated mineralocorticoid-induced cardiac hypertrophy and fibrosis. 42 Mineralocorticoid-induced cardiac fibrosis involves SGK1-dependent upregulation of CTGF, 42 a key mediator of extracellular matrix protein formation. CTGF expression was substantially reduced in the surviving LV myocardium of chronically infarcted MR MLCCre mice. Thus, lower SGK1 levels in MR MLCCre mice beneficially affect postinfarction ventricular remodeling by dual mechanisms: inhibition of cardiomyocyte hypertrophic response and prevention of CTGF profibrotic effects.
SGK1 has also been implicated in cardiomyocyte survival in vitro. 41 However, the reduction in apoptotic cardiomyocytes in MR MLCCre mice indicates that, despite SGK1 downregulation, MR-deficient cardiomyocytes are protected against apoptosis. These data are in line with several reports demonstrating that MR activation induces cardiomyocyte apoptosis. 26, 27 Because apoptotic cardiomyocyte loss early after MI contributes to LV dilation and failure, 43 inhibition of cardiomyocyte apoptosis by MR ablation likely restrained postinfarction remodeling in MR MLCCre mice. Protection of cardiomyocytes against apoptosis in MR-deficient mice appears to be mediated through an NF-B pathway. Using an elegant transgenic mouse model with cardiac-restricted expression of a mutated IB␣ protein, Misra et al 25 showed that activation of NF-B prevents cardiomyocyte apoptosis during the first hours after MI. While aldosterone via MR activation abrogates IB␣ degradation and NF-B activation, 24 we observed substantially lower IB␣ protein levels and increased NF-B DNA binding activity in cardiomyocytes from MR MLCCre mice after 90 minutes after coronary ligation.
The role of NF-B after MI is controversial and appears to be time dependent. While NF-B protects cardiomyocytes against apoptosis during the first hours after ischemia, 25, 44 persistent activation of NF-B mediates maladaptive LV remodeling and functional deterioration. 23 Noteworthy, our studies performed on cardiomyocytes isolated from adult MR MLCCre mice suggest that both stress-induced NF-B activation and subsequent suppression were faster in cardiomyocytes lacking the MR.
There are several potential mechanisms for improved infarct healing in MR MLCCre mice. Rapidly induced NF-B activation in MR-deficient cardiomyocytes during the first minutes after ischemia may have triggered the manifold cellular activities that underscore the processes of inflammation and healing. NF-B is a key signaling component for early inflammatory activation and recruitment of inflammatory cells after MI. 23 Exogenous glucocorticoids, which inhibit NF-B activation and inflammatory cell infiltration, impair infarct wound healing, resulting in adverse early LV dilation. 23 Optimal infarct healing is closely linked to rapid recruitment of inflammatory cells, timely inflammatory pathway suppression, neovessel formation, and deposition of collagenbased matrix. 8, 22, 23, 45 Thus, accelerated recruitment of neutrophils and monocytes, associated with upregulation of the angiogenic cytokine VEGF, likely contributed to enhanced neovascularization, resulting in reduced infarct expansion and improved early LV function in MR-deficient mice. Increased recruitment of neutrophils and macrophages within the first days after MI has recently been shown to lead to enhanced neovascularization, a reduction in infarct thinning, and functional improvement in 11␤HSD1-deficient mice. 46 The improved collagen structural organization in the infarct scar in MR MLCCre mice may also be of particular importance, most likely secondary to MMP downregulation. 21 Disorganized collagen matrix renders the scar less resistant to distention during overload and predisposes to thinning and dilatation of the infarcted wall, paving the way for progressive global ventricular dilation, LV dysfunction, and heart failure. [21] [22] [23] Although the sequence of events cannot easily be elucidated in vivo in the animal model, mechanisms such as reduced infarct expansion and early dilatation of the LV cavity, associated with a decrease in myocardial wall stress, likely contributed to the improvement in cardiac remodeling, contractile dysfunction, and heart failure. Increased wall stress in the noninfarcted myocardium triggers a cascade of molecular, cellular, and physiological responses that can lead to further cardiac dilation and pathological remodeling, including hypertrophic cardiac growth and fibrosis. 15 We cannot exclude that MR-mediated effects on fibroblasts and endothelial cells may also be involved in heart failure progression after MI. While MR activation in cardiac fibroblasts stimulates collagen synthesis and proliferation, 47 in endothelial cells, MR activation enhances generation of reactive oxygen species and impairs vascular reactivity. 14 However, the present study provides evidence that the cardiomyocyte MR plays a central role in healing and remodeling after MI.
From a clinical viewpoint, our results provide important new insights into the mechanisms underlying cardioprotection by MR blockade and add further evidence that more favorable effects on LV remodeling can be achieved by immediate initiation of MR blockade after MI. This should be tested in a randomized prospective trial in patients with acute coronary syndromes. Of note, in a retrospective analysis of the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS), 3, 4 earlier MR antagonism with eplerenone (3 to 7 days after MI) was associated with more favorable outcomes compared with later initiation (7 to 14 days after MI).
Conclusions
Cardiomyocyte-specific inactivation of the MR gene protects against adverse cardiac remodeling and contractile dysfunction in ischemic heart failure. The beneficial cardiac effects are likely attributable to improved infarct healing and prevention of cardiomyocyte hypertrophy, extracellular matrix accumulation, and myocardial oxidative stress. These data may indicate that clinical benefits of MR blockade in patients with acute or chronic heart failure are mediated largely via a cardiomyocyte-dependent mechanism.
